| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.555 | 0.011 | 0.555 | HERG channel blocker | 0.364 0.034 CID_154699752 | ||
| 0.531 | 0.012 | 0.531 | Potassium channel (Voltage-sensitive) blocker | 0.348 0.037 CID_154699752 | ||
| 0.513 | 0.005 | 0.513 | 5 Hydroxytryptamine 2 antagonist | 0.121 0.058 CID_154699752 | ||
| 0.538 | 0.039 | 0.538 | Analgesic | 0.252 0.181 CID_154699987 0.455 0.063 CID_154699752 | ||
| 0.487 | 0.005 | 0.487 | 5 Hydroxytryptamine 2C antagonist | 0.105 0.042 CID_154699752 | ||
| 0.488 | 0.013 | 0.545 | Anticonvulsant | 0.545 0.009 CID_154699752 | CID_154699752 | |
| 0.446 | 0.005 | 0.446 | 5 Hydroxytryptamine 2A antagonist | 0.088 0.054 CID_154699752 | ||
| 0.445 | 0.016 | 0.542 | Potassium channel blocker | 0.542 0.008 CID_154699752 | CID_154699752 | |
| 0.407 | 0.02 | 0.407 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.283 0.077 CID_154699987 0.287 0.074 CID_154699752 | ||
| 0.404 | 0.021 | 0.404 | Sigma receptor agonist | 0.118 0.117 CID_154699752 | ||
| 0.385 | 0.012 | 0.385 | 5 Hydroxytryptamine antagonist | |||
| 0.344 | 0.016 | 0.344 | Ca(v)3.3 blocker | 0.277 0.065 CID_154699987 0.303 0.039 CID_154699752 | ||
| 0.286 | 0.006 | 0.286 | 5 Hydroxytryptamine 1F antagonist | 0.066 0.053 CID_154699987 0.107 0.029 CID_154699752 | ||
| 0.279 | 0.016 | 0.279 | 5 Hydroxytryptamine 2B antagonist | 0.102 0.082 CID_154699752 | ||
| 0.223 | 0.007 | 0.223 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.262 | 0.047 | 0.262 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.157 0.119 CID_154699752 | ||
| 0.269 | 0.055 | 0.269 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.255 | 0.044 | 0.255 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.126 0.11 CID_154699752 | ||
| 0.271 | 0.065 | 0.271 | Tumour necrosis factor alpha release inhibitor | |||
| 0.272 | 0.091 | 0.288 | Nootropic | 0.288 0.08 CID_154699752 | CID_154699752 | |
| 0.187 | 0.013 | 0.187 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.329 | 0.175 | 0.329 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.157 | 0.011 | 0.157 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.159 | 0.022 | 0.159 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.231 | 0.095 | 0.231 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.21 0.14 CID_154699987 0.213 0.132 CID_154699752 | ||
| 0.23 | 0.096 | 0.281 | Cardiotonic | 0.281 0.065 CID_154699752 | CID_154699752 | |
| 0.183 | 0.061 | 0.183 | Antipruritic | |||
| 0.148 | 0.026 | 0.148 | Dopamine antagonist | |||
| 0.15 | 0.029 | 0.15 | Alpha 1 adrenoreceptor antagonist | 0.137 0.032 CID_154699752 | ||
| 0.144 | 0.024 | 0.144 | Alpha 1a adrenoreceptor antagonist | 0.105 0.034 CID_154699752 | ||
| 0.147 | 0.028 | 0.147 | Nav1.5 sodium channel blocker | |||
| 0.153 | 0.037 | 0.169 | Alpha adrenoreceptor antagonist | 0.169 0.033 CID_154699752 | CID_154699752 | |
| 0.142 | 0.026 | 0.142 | Nitric-oxide synthase inhibitor | |||
| 0.144 | 0.029 | 0.144 | Insulin receptor antagonist | |||
| 0.137 | 0.026 | 0.137 | Acetylcholine M3 receptor agonist | 0.074 0.066 CID_154699987 0.112 0.038 CID_154699752 | ||
| 0.134 | 0.025 | 0.134 | Dopamine D2 antagonist | |||
| 0.272 | 0.164 | 0.272 | MAP kinase kinase 6 inhibitor | |||
| 0.161 | 0.059 | 0.161 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.136 | 0.037 | 0.136 | Antihistaminic | |||
| 0.131 | 0.035 | 0.131 | Histamine antagonist | |||
| 0.15 | 0.056 | 0.15 | Toll-Like receptor antagonist | |||
| 0.134 | 0.04 | 0.134 | Alpha 2c adrenoreceptor antagonist | |||
| 0.206 | 0.114 | 0.346 | Spasmolytic | 0.346 0.054 CID_154699752 | CID_154699752 | |
| 0.136 | 0.046 | 0.136 | Alpha 2b adrenoreceptor antagonist | |||
| 0.12 | 0.035 | 0.37 | NMDA receptor antagonist | 0.37 0.005 CID_154699752 | CID_154699752 | |
| 0.096 | 0.015 | 0.096 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.11 | 0.032 | 0.11 | Alpha 1b adrenoreceptor antagonist | 0.086 0.042 CID_154699752 | ||
| 0.2 | 0.123 | 0.2 | MAP kinase kinase 3 inhibitor | 0.187 0.165 CID_154699987 0.189 0.158 CID_154699752 | ||
| 0.099 | 0.026 | 0.099 | Dopamine D4 antagonist | |||
| 0.103 | 0.031 | 0.103 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.083 | 0.011 | 0.125 | Potassium channel (Inward rectifier) blocker | 0.125 0.005 CID_154699752 | CID_154699752 | |
| 0.097 | 0.026 | 0.097 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.179 | 0.109 | 0.179 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.088 | 0.018 | 0.088 | Sigma receptor antagonist | 0.057 0.03 CID_154699752 | ||
| 0.11 | 0.042 | 0.11 | Glutamate (mGluR7) agonist | |||
| 0.122 | 0.054 | 0.122 | 5 Hydroxytryptamine 3A agonist | |||
| 0.129 | 0.064 | 0.129 | Nav1.3 sodium channel blocker | |||
| 0.123 | 0.064 | 0.13 | Acetylcholine muscarinic antagonist | 0.13 0.058 CID_154699752 | CID_154699752 | |
| 0.08 | 0.022 | 0.08 | Calcium channel T-type blocker | |||
| 0.091 | 0.035 | 0.091 | Ca(v)3.1 blocker | |||
| 0.084 | 0.029 | 0.084 | Phospholipase D inhibitor | 0.07 0.053 CID_154699752 | ||
| 0.123 | 0.071 | 0.142 | Cholinergic antagonist | 0.142 0.057 CID_154699752 | CID_154699752 | |
| 0.121 | 0.069 | 0.14 | Acetylcholine antagonist | 0.14 0.056 CID_154699752 | CID_154699752 | |
| 0.127 | 0.076 | 0.127 | Nav1.2 sodium channel blocker | |||
| 0.114 | 0.065 | 0.114 | Calcium channel (voltage-sensitive) blocker | |||
| 0.088 | 0.04 | 0.088 | CC chemokine 5 receptor agonist | |||
| 0.057 | 0.009 | 0.057 | 5 Hydroxytryptamine 1D agonist | |||
| 0.08 | 0.034 | 0.08 | 5 Hydroxytryptamine uptake inhibitor | 0.078 0.035 CID_154699752 | ||
| 0.091 | 0.047 | 0.091 | Histamine H1 receptor antagonist | |||
| 0.063 | 0.019 | 0.063 | CC chemokine 3 receptor antagonist | 0.043 0.028 CID_154699752 | ||
| 0.085 | 0.041 | 0.244 | NMDA 2 receptor antagonist | 0.244 0.006 CID_154699752 | CID_154699752 | |
| 0.084 | 0.04 | 0.084 | 5 Hydroxytryptamine agonist | |||
| 0.09 | 0.046 | 0.09 | Opioid kappa receptor antagonist | 0.073 0.07 CID_154699752 | ||
| 0.076 | 0.035 | 0.076 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.05 | 0.009 | 0.05 | Dipeptidyl peptidase I inhibitor | 0.032 0.02 CID_154699987 | ||
| 0.103 | 0.063 | 0.103 | Nav1.1 sodium channel blocker | |||
| 0.092 | 0.055 | 0.092 | Opioid antagonist | |||
| 0.085 | 0.05 | 0.085 | Acetylcholine nicotinic agonist | |||
| 0.059 | 0.024 | 0.059 | Purinergic P2X antagonist | |||
| 0.052 | 0.017 | 0.052 | Baculoviral IAP repeat-containing protein inhibitor | |||
| 0.082 | 0.048 | 0.082 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.057 | 0.023 | 0.057 | Histamine H3 receptor antagonist | |||
| 0.064 | 0.03 | 0.064 | 5 Hydroxytryptamine 1 agonist | |||
| 0.056 | 0.023 | 0.056 | Neurokinin 3 antagonist | |||
| 0.053 | 0.022 | 0.053 | Neurokinin 2 antagonist | |||
| 0.061 | 0.029 | 0.061 | 5 Hydroxytryptamine 7 agonist | |||
| 0.047 | 0.016 | 0.047 | Nociceptin (N/OFQ) receptor antagonist | 0.038 0.022 CID_154699752 | ||
| 0.043 | 0.012 | 0.043 | Sigma 2 receptor antagonist | |||
| 0.145 | 0.117 | 0.145 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.047 | 0.021 | 0.047 | DNA gyrase subunit A inhibitor | 0.046 0.022 CID_154699752 | ||
| 0.055 | 0.029 | 0.055 | Neurokinin antagonist | |||
| 0.061 | 0.035 | 0.061 | Ca(v)3.2 blocker | |||
| 0.089 | 0.064 | 0.089 | Hepatocyte growth factor antagonist | |||
| 0.064 | 0.039 | 0.064 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.067 | 0.042 | 0.067 | Dopamine D1 antagonist | |||
| 0.058 | 0.033 | 0.058 | Protein kinase C epsilon inhibitor | |||
| 0.061 | 0.037 | 0.067 | Dopamine uptake inhibitor | 0.067 0.032 CID_154699752 | CID_154699752 | |
| 0.085 | 0.061 | 0.091 | Insulin growth factor antagonist | 0.091 0.054 CID_154699752 | CID_154699752 | |
| 0.082 | 0.058 | 0.086 | Insulin like growth factor 1 antagonist | 0.086 0.054 CID_154699752 | CID_154699752 | |
| 0.24 | 0.217 | 0.418 | Calcium channel L-type activator | 0.235 0.222 CID_154699987 0.418 0.069 CID_154699752 | CID_154699752 | |
| 0.113 | 0.093 | 0.113 | Sodium channel blocker | |||
| 0.082 | 0.061 | 0.082 | Histamine H2 receptor antagonist | |||
| 0.061 | 0.04 | 0.061 | Potassium channel (Ca-activated) blocker | |||
| 0.036 | 0.016 | 0.036 | Protein kinase C beta I inhibitor | 0.033 0.025 CID_154699987 0.034 0.021 CID_154699752 | ||
| 0.074 | 0.055 | 0.074 | Analgesic, opioid | |||
| 0.063 | 0.045 | 0.063 | Purinergic P2 antagonist | |||
| 0.062 | 0.043 | 0.062 | Dopamine D3 antagonist | |||
| 0.08 | 0.062 | 0.08 | Caspase 7 inhibitor | |||
| 0.032 | 0.015 | 0.034 | DNA topoisomerase IV inhibitor | 0.034 0.014 CID_154699752 | CID_154699752 | |
| 0.054 | 0.039 | 0.058 | Protein kinase C eta inhibitor | 0.058 0.036 CID_154699752 | CID_154699752 | |
| 0.026 | 0.011 | 0.026 | Nociceptin (N/OFQ) receptor agonist | 0.024 0.013 CID_154699752 | ||
| 0.023 | 0.009 | 0.023 | Baculoviral IAP repeat-containing protein 3 inhibitor | |||
| 0.056 | 0.043 | 0.056 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.063 | 0.051 | 0.063 | Acetylcholine M5 receptor agonist | |||
| 0.12 | 0.108 | 0.147 | Acetylcholine M1 receptor antagonist | 0.147 0.077 CID_154699752 | CID_154699752 | |
| 0.081 | 0.07 | 0.178 | Antiadrenergic | 0.178 0.029 CID_154699752 | CID_154699752 | |
| 0.055 | 0.045 | 0.055 | Alpha 1d adrenoreceptor antagonist | |||
| 0.045 | 0.036 | 0.045 | Proto-oncogene tyrosine-protein kinase Met inhibitor | |||
| 0.078 | 0.07 | 0.175 | Adrenaline antagonist | 0.175 0.029 CID_154699752 | CID_154699752 | |
| 0.066 | 0.058 | 0.066 | MAP kinase 14 inhibitor | |||
| 0.074 | 0.066 | 0.074 | Protein kinase A inhibitor | |||
| 0.039 | 0.031 | 0.039 | Neurokinin 1 antagonist | |||
| 0.026 | 0.019 | 0.026 | Sigma 1 receptor antagonist | |||
| 0.049 | 0.042 | 0.049 | Opioid agonist | |||
| 0.031 | 0.025 | 0.031 | Protein kinase C beta II inhibitor | |||
| 0.047 | 0.042 | 0.047 | Sodium/calcium exchanger inhibitor | |||
| 0.046 | 0.042 | 0.046 | CC chemokine 5 receptor antagonist | |||
| 0.01 | 0.005 | 0.01 | Baculoviral IAP repeat-containing protein 2 inhibitor | |||
| 0.067 | 0.062 | 0.067 | Alpha 2a adrenoreceptor antagonist | |||
| 0.026 | 0.022 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.051 | 0.047 | 0.051 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.056 | 0.052 | 0.056 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.049 | 0.045 | 0.049 | Acetylcholine M2 receptor agonist | |||
| 0.1 | 0.097 | 0.1 | Interleukin 8 antagonist | |||
| 0.063 | 0.061 | 0.063 | Polo-like kinase-2 inhibitor | |||
| 0.028 | 0.027 | 0.056 | Potassium channel (Inward rectifier) 1 blocker | 0.056 0.004 CID_154699752 | CID_154699752 | |
| 0.051 | 0.057 | 0.066 | Adrenaline uptake inhibitor | 0.066 0.038 CID_154699752 | CID_154699752 | |
| 0.197 | 0.211 | 0.29 | Antiobesity | 0.29 0.124 CID_154699752 | CID_154699752 | |
| 0.076 | 0.093 | 0.14 | Chemokine receptor antagonist | 0.14 0.037 CID_154699987 | CID_154699987 | |
| 0.098 | 0.115 | 0.153 | Transcription factor STAT6 inhibitor | 0.153 0.021 CID_154699987 0.111 0.078 CID_154699752 | CID_154699987 | |
| 0.059 | 0.081 | 0.117 | CC chemokine receptor antagonist | 0.117 0.027 CID_154699987 0.07 0.063 CID_154699752 | CID_154699987 | |
| 0.034 | 0.058 | 0.044 | Dopamine transporter inhibitor | 0.044 0.039 CID_154699752 | CID_154699752 | |
| 0.03 | 0.06 | 0.038 | Acetyl-CoA carboxylase inhibitor | 0.038 0.034 CID_154699752 | CID_154699752 | |
| 0.03 | 0.064 | 0.04 | Stearoyl-CoA desaturase inhibitor | 0.04 0.037 CID_154699752 | CID_154699752 | |
| 0.038 | 0.077 | 0.209 | NMDA 2B receptor antagonist | 0.209 0.005 CID_154699752 | CID_154699752 | |
| 0.08 | 0.128 | 0.17 | Glutamate receptor antagonist | 0.17 0.039 CID_154699752 | CID_154699752 | |
| 0.169 | 0.246 | 0.216 | Toll-Like receptor 7 agonist | 0.216 0.182 CID_154699752 | CID_154699752 | |
| 0.101 | 0.189 | 0.143 | EphB2 antagonist | 0.143 0.136 CID_154699752 | CID_154699752 | |
| 0.034 | 0.123 | 0.063 | Alpha adrenoreceptor agonist | 0.063 0.052 CID_154699752 | CID_154699752 | |
| 0.025 | 0.121 | 0.054 | Alpha 1 adrenoreceptor agonist | 0.054 0.045 CID_154699752 | CID_154699752 | |
| 0.161 | 0.257 | 0.21 | Toll-Like receptor agonist | 0.21 0.19 CID_154699752 | CID_154699752 | |
| 0.044 | 0.164 | 0.059 | Beta 2 adrenoreceptor agonist | 0.059 0.056 CID_154699752 | CID_154699752 | |
| 0.076 | 0.201 | 0.129 | Neurotrophic factor | 0.129 0.081 CID_154699752 | CID_154699752 | |
| 0.177 | 0.31 | 0.237 | Cyclophilin D inhibitor | 0.237 0.228 CID_154699752 | CID_154699752 | |
| 0.035 | 0.201 | 0.09 | Adrenaline agonist | 0.09 0.046 CID_154699752 | CID_154699752 | |
| 0.141 | 0.325 | 0.217 | Calcium channel activator | 0.217 0.189 CID_154699752 | CID_154699752 | |
| 0.031 | 0.239 | 0.064 | Beta 3 adrenoreceptor antagonist | 0.064 0.046 CID_154699752 | CID_154699752 | |
| 0.114 | 0.339 | 0.193 | Peptidyltransferase inhibitor | 0.193 0.109 CID_154699752 | CID_154699752 | |
| 0.129 | 0.362 | 0.213 | Interleukin 2 agonist | 0.213 0.168 CID_154699752 | CID_154699752 | |
| 0.032 | 0.281 | 0.145 | Bronchodilator | 0.145 0.033 CID_154699752 | CID_154699752 | |
| 0.071 | 0.478 | 0.258 | Antibacterial | 0.258 0.169 CID_154699752 | CID_154699752 | |
| 0.062 | 0.514 | 0.661 | Immunomodulator | 0.661 0.007 CID_154699987 | CID_154699987 | |
| 0.04 | 0.571 | 0.187 | Transcription factor STAT inhibitor | 0.187 0.157 CID_154699987 | CID_154699987 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |